Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

NCT03809481 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Prolonged delay as a result of impact of Covid19 pandemic

Conditions

Heparin-induced Thrombocytopenia

Interventions

DRUG: Danaparoid Sodium
DRUG: Argatroban

Sponsor

Aspen Global Incorporated